Kezar Life Sciences, Inc. (KZR)
7.33
-0.04
(-0.54%)
USD |
NASDAQ |
Apr 17, 16:00
7.34
+0.01
(+0.14%)
After-Hours: 20:00
Kezar Life Sciences EPS Diluted (Quarterly) : -1.985 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Apellis Pharmaceuticals, Inc. | -0.4654 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.55M |
| Total Expenses (Quarterly) | 14.55M |
| Enterprise Value | -15.52M |
| Earnings Yield | -104.5% |
| Normalized Earnings Yield | -95.39 |